H2S‐Activable MOF Nanoparticle Photosensitizer for Effective Photodynamic Therapy against Cancer with Controllable Singlet‐Oxygen Release

Angewandte Chemie - International Edition - Tập 56 Số 44 - Trang 13752-13756 - 2017
Yu Ma1, Xiangyuan Li1, Aijie Li1, Peng Yang1, Caiyun Zhang1, Bo Tang1
1College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes (Ministry of Education), Institute of Molecular and Nano Science, Shandong Normal University, Jinan 250014, P. R. China

Tóm tắt

Abstract

Photodynamic therapy (PDT) has emerged as an important minimally invasive tumor treatment technology. The search for an effective photosensitizer to realize selective cancer treatment has become one of the major foci in recent developments of PDT technology. Controllable singlet‐oxygen release based on specific cancer‐associated events, as another major layer of selectivity mode, has attracted great attention in recent years. Here, for the first time, we demonstrated that a novel mixed‐metal metal–organic framework nanoparticle (MOF NP) photosensitizer can be activated by a hydrogen sulfide (H2S) signaling molecule in a specific tumor microenvironment for PDT against cancer with controllable singlet‐oxygen release in living cells. The effective removal of tumors in vivo further confirmed the satisfactory treatment effect of the MOF NP photosensitizer.

Từ khóa


Tài liệu tham khảo

 

10.1038/nrc1071

10.1016/j.addr.2008.08.003

10.1021/cr400532z

 

10.1038/nrd1984

10.1038/nrc3297

 

10.1039/B915149B

10.1021/ja801631c

10.1021/acsnano.5b04501

 

10.3390/ma6030817

10.1016/j.pdpdt.2010.02.001

10.1021/cr900236h

 

10.1016/j.canlet.2012.09.012

10.1146/annurev-med-040210-162544

10.1016/j.ccr.2015.08.008

 

10.1021/jacs.6b00007

10.1002/anie.201602417

10.1002/ange.201602417

10.1021/ja508679h

10.1021/jacs.5b04069

10.1021/jacs.6b06663

10.1073/pnas.1306241110

Josefsen L. B., 2008, Met.-Based Drugs, 276109

 

10.1021/ja207851s

10.1021/ac503622n

10.1016/j.snb.2016.11.085

10.1021/acsami.6b12118

10.1039/c0dt01401j

10.1021/ja307953m

10.1021/la902235d

 

10.1021/nl052396o

10.1002/anie.201203767

10.1002/ange.201203767